MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-5407

  1. 268 Posts.
    lightbulb Created with Sketch. 41
    It's more primary research for the future~ More autologous centric~ More iPSC in vitro differentiation~ Basically researchers taking some easy money...

    https://www.mcri.edu.au/stem-cell/medicine
    Our expertise at the Murdoch Children’s Research Institute lies in our excellence in the generation of stem cells from a patient’s blood or skin cells known as induced pluripotent stem cells (iPSCs) and the subsequent differentiation of those stem cells into specialised tissues we wish to study – for example blood, kidney, brain or heart. This provides the potential for medical application in patient-based disease modelling and the development of treatments at MCRI for:
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.19
Change
0.085(7.69%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.10 $1.20 $1.09 $13.21M 11.37M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.19
 

Sellers (Offers)

Price($) Vol. No.
$1.19 75212 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.